Children’s Hospital ColoradoAurora, Colorado, United States
Disclosure information not submitted.
MON-225 - A Multicenter, Phase 2, Dose-Escalation/Dose-Expansion Study of Dabogratinib (Formerly TYRA-300) in Children with Achondroplasia with Open Growth Plates: BEACH301
Monday, June 15, 20269:00 AM - 2:00 PM CT